Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide
- 1 December 2006
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 149 (8), 988-997
- https://doi.org/10.1038/sj.bjp.0706953
Abstract
3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) are frequently used lipid-lowering drugs. Moreover, they exert pleiotropic effects on cellular stress responses and death. Here, we analysed whether lovastatin affects the sensitivity of primary human endothelial cells (HUVEC) to the anticancer drug doxorubicin. We investigated whether pretreatment of HUVEC with low dose of lovastatin influences the cellular sensitivity to doxorubicin. To this end, cell viability, proliferation and apoptosis as well as DNA damage-triggered stress response were analysed. Lovastatin reduced the cytotoxic potency of doxorubicin in HUVEC. Lovastatin attenuated the doxorubicin-induced increase in p53 as well as activation of checkpoint kinase (Chk-1) and stress-activated protein kinase/c-Jun-N-terminal kinase (SAPK/JNK). Acquired doxorubicin resistance was independent of alterations in doxorubicin efflux and cell cycle progression. Also, doxorubicin-triggered production of reactive oxygen species (ROS) and formation of oxidative DNA lesions remained unaffected by lovastatin. However, lovastatin impaired DNA strand break formation induced by doxorubicin. Notably, lovastatin also conferred cross-resistance to the cytotoxic and genotoxic effects of etoposide, indicating that lovastatin shields topoisomerase II against poisons. Based on these data, we suggest that lovastatin-mediated resistance to topoisomerase II inhibitors is due to a reduction in DNA damage and, hence, it attenuates stress responses leading to cell death that are triggered by DNA damage. Therefore, lovastatin might be useful clinically for alleviating side-effects of anticancer therapies that include topoisomerase II inhibitors.Keywords
This publication has 68 references indexed in Scilit:
- Direct Involvement of the Small GTPase Rac in Activation of the Superoxide-producing NADPH Oxidase Nox1Published by Elsevier BV ,2006
- PLEIOTROPIC EFFECTS OF STATINSAnnual Review of Pharmacology and Toxicology, 2005
- Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart FailureCirculation, 2005
- Caspase-2 function in response to DNA damageBiochemical and Biophysical Research Communications, 2005
- Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxideLife Sciences, 2005
- Doxorubicin treatment in vivo activates caspase‐12 mediated cardiac apoptosis in both male and female ratsFEBS Letters, 2004
- Human Topoisomerase IIα and IIβ Interact with the C-Terminal Region of p53Experimental Cell Research, 2000
- Effects of wild-type p53 expression on the quantity and activity of topoisomerase II? and ? in various human cancer cell linesJournal of Cellular Biochemistry, 1999
- Anthrazykline in der KrebstherapieDrugs, 1997
- Three paths to stress reliefNature, 1996